Biomaterial Database

SERUM CREATINE KINASE, LACTIC DEHYDROGENASE, AND GLUTAMIC-OXALACETIC TRANSAMINASE IN THYROID DISEASES AND PREGNANCY. 1965

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

UI	MeSH Term	Description	Entries
D006980	Hyperthyroidism	Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.	Hyperthyroid,Primary Hyperthyroidism,Hyperthyroidism, Primary,Hyperthyroids
D007037	Hypothyroidism	A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.	Central Hypothyroidism,Primary Hypothyroidism,Secondary Hypothyroidism,TSH Deficiency,Thyroid-Stimulating Hormone Deficiency,Central Hypothyroidisms,Deficiency, TSH,Deficiency, Thyroid-Stimulating Hormone,Hormone Deficiency, Thyroid-Stimulating,Hypothyroidism, Central,Hypothyroidism, Primary,Hypothyroidism, Secondary,Hypothyroidisms,Primary Hypothyroidisms,Secondary Hypothyroidisms,TSH Deficiencies,Thyroid Stimulating Hormone Deficiency,Thyroid-Stimulating Hormone Deficiencies
D007770	L-Lactate Dehydrogenase	A tetrameric enzyme that, along with the coenzyme NAD+, catalyzes the interconversion of LACTATE and PYRUVATE. In vertebrates, genes for three different subunits (LDH-A, LDH-B and LDH-C) exist.	Lactate Dehydrogenase,Dehydrogenase, L-Lactate,Dehydrogenase, Lactate,L Lactate Dehydrogenase
D009230	Myxedema	A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.	Myxedemas
D010088	Oxidoreductases	The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9)	Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D011247	Pregnancy	The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	Gestation,Pregnancies
D001769	Blood	The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D003402	Creatine Kinase	A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins.	Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004796	Clinical Enzyme Tests	Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.	Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Glutamic oxalacetic transaminase and lactic dehydrogenase in pregnancy.

July 1960, American journal of obstetrics and gynecology,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Serum lactic dehydrogenase and glutamic oxalacetic transaminase activites in normal pregnancy.

May 1958, The Journal of laboratory and clinical medicine,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Simultaneous human serum glutamic oxalacetic transaminase; serum glutamic pyruvic transaminase and serum lactic dehydrogenase determinations.

July 1961, The Ceylon medical journal,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Glutamic oxalacetic transaminase, lactic dehydrogenase, and creatine phosphokinase content in cerebrospinal fluid.

July 1971, Cleveland Clinic quarterly,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Normal values for serum glutamic oxalacetic transaminase and lactic dehydrogenase activites.

August 1966, Technical bulletin of the Registry of Medical Technologists. American Society of Clinical Pathologists. Registry of Medical Technologists,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Normal values for serum glutamic oxalacetic transaminase and lactic dehydrogenase activities.

September 1966, American journal of clinical pathology,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

[Enzymatic activity (glutamic oxalacetic transaminase, glutamic pyruvic transaminase & lactic acid dehydrogenase, in alcoholism].

January 1959, Svenska lakartidningen,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Transaminase activity in coronary heart disease; determinations of serum lactic dehydrogenase, glutamic oxalacetic transaminase, and glutamic pyruvic transaminase activity.

May 1959, The American journal of cardiology,

G A FLEISHER, and W M MCCONAHEY, and M PANKOW

Serum enzymes in disease. II. Lactic dehydrogenase and glutamic oxalacetic transaminase in anemia.

July 1958, A.M.A. archives of internal medicine,